Delivery Order SPE2DB22D3301-SPE2DB25FZ0BE
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,988.46 by the Defense Logistics Agency (DLA) on October 8, 2025, for the supply of Gamunex-C 10 gram/100 milliliter vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 30, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,180.13 on August 6, 2025, for GAMUNEX-C 20 GR/200 1S, a specialized pharmaceutical product. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for GAMUNEX-C 40 gram/400 mL vials, with a ceiling value of $142,233.12. This firm fixed price delivery order, issued on November 18, 2025, is scheduled for ultimate completion by December 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a non-competitive, sole-source delivery order placed against the company's existing indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,001.00 for GAMUNEX-C 5 gram/50 mL vials on November 14, 2025, with a completion date of December 8, 2025. This firm fixed-price contract is a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $18,314.10 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 10 gram/100 mL vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contract will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on April 25, 2025, for the supply of Gamunex-C 40 gram/400 milliliter vials. The contract ceiling value is $34,908.00, with an ultimate completion date of May 16, 2025. This delivery order was competitively awarded with no set-aside designation and represents part of AmerisourceBergen's ongoing support of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,925.84 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 gram/400 ml vials, with an ultimate completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 3, 2025, for the supply of Gamunex-C 10 gram/100 mL vials. The contract carries a ceiling value of $1,831.41 with a firm fixed price structure and an ultimate completion date of September 24, 2025. This award represents a competitive procurement with no set-aside designation and reflects AmerisourceBergen's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of GAMUNEX-C 10 gram/100 mL vials valued at $6,092.18 with a completion date of November 10, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 9, 2025, and was awarded on September 18, 2025. This award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. The performance location...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0BEDelivery Order
AmerisourceBergen Drug Corp was awarded a $14,161.68 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials. The order is scheduled for completion by September 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded and represents a continuation of the company's pharmaceutical supply services to federal military and healthcare customers. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's role as a prime vendor reflects the DLA's reliance on established pharmaceutical distributors to ensure consistent availability of critical medical commodities across the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 8/26/25 |